0001209191-22-032172.txt : 20220526 0001209191-22-032172.hdr.sgml : 20220526 20220526161000 ACCESSION NUMBER: 0001209191-22-032172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220524 FILED AS OF DATE: 20220526 DATE AS OF CHANGE: 20220526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knobil Katharine CENTRAL INDEX KEY: 0001768011 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 22970028 MAIL ADDRESS: STREET 1: C/O KALEIDO BIOSCIENCES, INC. STREET 2: 65 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-24 0 0001094038 Marker Therapeutics, Inc. MRKR 0001768011 Knobil Katharine C/O MARKER THERAPEUTICS, INC. 3200 SOUTHWEST FREEWAY, SUITE 2500 HOUSTON TX 77027 1 0 0 0 Stock Option (Right to Buy) 0.3377 2022-05-24 4 A 0 80000 0.00 A 2032-05-23 Common Stock 80000 80000 D This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date. /s/ Michael Loiacono, Attorney-in-Fact 2022-05-26